Effective genetic vaccination with a widely shared endogenous retroviral tumor antigen requires CD40 stimulation during tumor rejection phase. (Q40609370)
Jump to navigation
Jump to search
scientific article published on December 2003
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Effective genetic vaccination with a widely shared endogenous retroviral tumor antigen requires CD40 stimulation during tumor rejection phase. |
scientific article published on December 2003 |
Statements
Effective genetic vaccination with a widely shared endogenous retroviral tumor antigen requires CD40 stimulation during tumor rejection phase (English)
Vincenzo Bronte
Elisa Apolloni
Paolo Serafini
Ilaria Marigo
Carmela De Santo
Beatrice Macino
Oriano Marin
1 December 2003